These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 29731021)

  • 1. Pathophysiological Links Between Diabetes and Blood Pressure.
    Libianto R; Batu D; MacIsaac RJ; Cooper ME; Ekinci EI
    Can J Cardiol; 2018 May; 34(5):585-594. PubMed ID: 29731021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms.
    Hall JE; do Carmo JM; da Silva AA; Wang Z; Hall ME
    Circ Res; 2015 Mar; 116(6):991-1006. PubMed ID: 25767285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for a critical role of the sympathetic nervous system in hypertension.
    Grassi G; Ram VS
    J Am Soc Hypertens; 2016 May; 10(5):457-66. PubMed ID: 27052349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel interaction between sympathetic overactivity and aberrant regulation of renin by miR-181a in BPH/2J genetically hypertensive mice.
    Jackson KL; Marques FZ; Watson AM; Palma-Rigo K; Nguyen-Huu TP; Morris BJ; Charchar FJ; Davern PJ; Head GA
    Hypertension; 2013 Oct; 62(4):775-81. PubMed ID: 23897069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sympathetic nervous system, diabetes, and hypertension.
    Perin PC; Maule S; Quadri R
    Clin Exp Hypertens; 2001; 23(1-2):45-55. PubMed ID: 11270588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic Links Between Obesity, Diabetes, and Blood Pressure: Role of Perivascular Adipose Tissue.
    Saxton SN; Clark BJ; Withers SB; Eringa EC; Heagerty AM
    Physiol Rev; 2019 Oct; 99(4):1701-1763. PubMed ID: 31339053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Renin Angiotensin Aldosterone System in Obesity and Hypertension: Roles in the Cardiorenal Metabolic Syndrome.
    Cabandugama PK; Gardner MJ; Sowers JR
    Med Clin North Am; 2017 Jan; 101(1):129-137. PubMed ID: 27884224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic salt loading and cardiovascular-associated changes in experimental diabetes in rats.
    Maeda C; Schaan B; Oliveira E; Oliveira V; De Angelis K; Irigoyen M
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):574-80. PubMed ID: 17581211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the sympathetic nervous system in obesity-related hypertension.
    da Silva AA; do Carmo J; Dubinion J; Hall JE
    Curr Hypertens Rep; 2009 Jun; 11(3):206-11. PubMed ID: 19442330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological mechanism of angiotensin II receptor antagonists: implications for the treatment of elevated systolic blood pressure.
    Brooks DP; Ruffolo RR
    J Hypertens Suppl; 1999 Jun; 17(2):S27-32. PubMed ID: 10465064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renin-angiotensin-aldosterone system in diabetes mellitus.
    Christlieb AR
    Diabetes; 1976; 25(2 SUPPL):820-5. PubMed ID: 823063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin and blood pressure regulation.
    Gans RO; Donker AJ
    J Intern Med Suppl; 1991; 735():49-64. PubMed ID: 2043223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity, kidney dysfunction and hypertension: mechanistic links.
    Hall JE; do Carmo JM; da Silva AA; Wang Z; Hall ME
    Nat Rev Nephrol; 2019 Jun; 15(6):367-385. PubMed ID: 31015582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cilnidipine on sympathetic nerve activity and cardiorenal function in hypertensive patients with type 2 diabetes mellitus: association with BNP and aldosterone levels.
    Tanaka M; Sekioka R; Nishimura T; Ichihara A; Itoh H
    Diabetes Res Clin Pract; 2014 Dec; 106(3):504-10. PubMed ID: 25458339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity, kidney dysfunction, and inflammation: interactions in hypertension.
    Hall JE; Mouton AJ; da Silva AA; Omoto ACM; Wang Z; Li X; do Carmo JM
    Cardiovasc Res; 2021 Jul; 117(8):1859-1876. PubMed ID: 33258945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertension and diabetes: role of the renin-angiotensin system.
    Jandeleit-Dahm K; Cooper ME
    Endocrinol Metab Clin North Am; 2006 Sep; 35(3):469-90, vii. PubMed ID: 16959581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for renoprotection by blockade of the renin-angiotensin-aldosterone system in hypertension and diabetes.
    Karalliedde J; Viberti G
    J Hum Hypertens; 2006 Apr; 20(4):239-53. PubMed ID: 16452996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sympathetic Nervous System, Hypertension, Obesity and Metabolic Syndrome.
    Seravalle G; Grassi G
    High Blood Press Cardiovasc Prev; 2016 Sep; 23(3):175-9. PubMed ID: 26942609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sympathetic and renin-angiotensin systems contribute to increased blood pressure in sucrose-fed rats.
    Freitas RR; Lopes KL; Carillo BA; Bergamaschi CT; Carmona AK; Casarini DE; Furukawa L; Heimann JC; Campos RR; Dolnikoff MS
    Am J Hypertens; 2007 Jun; 20(6):692-8. PubMed ID: 17531930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertension and the kidneys.
    De Bhailis ÁM; Kalra PA
    Br J Hosp Med (Lond); 2022 May; 83(5):1-11. PubMed ID: 35653320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.